Metastasis-Directed Radiotherapy (MDRT) for Men with De-Novo Oligometastatic Prostate Cancer Treated with Long-Term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) (UH IRB)

Full Title

Metastasis-Directed Radiotherapy (MDRT) for Men with De-Novo Oligometastatic Prostate Cancer Treated with Long-Term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) (UH IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. James Janopaul-Naylor’s office at 646-983-4738.